These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30920991)

  • 21. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
    Rudd RA; Aleshire N; Zibbell JE; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain Management During West Virginia's Opioid Crisis.
    Haggerty T; Sedney CL; Dekeseredy P; Nwafor D; Brownstein HH; Caretta MA; Pollini RA
    J Am Board Fam Med; 2022 Oct; 35(5):940-950. PubMed ID: 36257694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of co-occurring substance use in individuals with opioid use disorder.
    Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
    Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk.
    Siegler A; Tuazon E; Bradley O'Brien D; Paone D
    Int J Drug Policy; 2014 May; 25(3):569-74. PubMed ID: 24412006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries.
    Peters JL; Durand WM; Monteiro KA; Dumenco L; George P
    J Am Board Fam Med; 2018; 31(6):881-896. PubMed ID: 30413544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response.
    Kanouse AB; Compton P
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):102-14. PubMed ID: 26095479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties.
    Janoff SL; Perrin NA; Coplan PM; Chilcoat HD; Campbell CI; Green CA
    BMC Pharmacol Toxicol; 2016 May; 17(1):21. PubMed ID: 27177423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
    Martins SS; Sampson L; Cerdá M; Galea S
    Am J Public Health; 2015 Nov; 105(11):2373. PubMed ID: 26451757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
    Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
    J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.
    Hall PB
    W V Med J; 2014; 110(6):6-10. PubMed ID: 25651658
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment.
    Popovici I; Maclean JC; Hijazi B; Radakrishnan S
    Health Econ; 2018 Feb; 27(2):294-305. PubMed ID: 28719096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
    Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
    JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention.
    Wagner KD; Liu L; Davidson PJ; Cuevas-Mota J; Armenta RF; Garfein RS
    Drug Alcohol Depend; 2015 Aug; 153():215-20. PubMed ID: 26091751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems.
    Cobaugh DJ; Gainor C; Gaston CL; Kwong TC; Magnani B; McPherson ML; Painter JT; Krenzelok EP
    Am J Health Syst Pharm; 2014 Sep; 71(18):1539-54. PubMed ID: 25174015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
    Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
    J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Opioid Epidemic: Crisis and Solutions.
    Skolnick P
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():143-159. PubMed ID: 28968188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.